|
Xenobiotic-Metabolizing Enzymes
|
ZIA BC 005562
|
$817,733
|
$613,299
|
Gonzalez, Frank
|
CCR (NCI)
|
|
Xenobiotic Receptors
|
ZIA BC 005708
|
$817,733
|
$490,639
|
Gonzalez, Frank
|
CCR (NCI)
|
|
WUMC Cancer and Leukemia Group B
|
5U10CA077440-14
|
$330,937
|
$112,519
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Workshops On Viral Oncogenesis and Pathogenesis
|
5R13CA095919-10
|
$5,000
|
$750
|
FAN, HUNG
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Women's Health Study: Continued Follow-up
|
5R01CA047988-20
|
$1,808,081
|
$361,616
|
BURING, JULIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Wnt Signaling in Colon Cancer
|
2R01CA108697-06A1
|
$299,453
|
$299,453
|
WATERMAN, MARIAN
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Whole-Body PET/CT Assessment of Tumor Perfusion Using Generator-Produced 62Cu
|
4R01CA140299-03
|
$420,747
|
$420,747
|
Fletcher, James
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Whole Genome Scan for Modifier Genes in Colorectal Cancer
|
5R01CA126895-04
|
$1,853,251
|
$1,853,251
|
LE MARCHAND, LOIC
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Vitamin D3 Metabolism and Colorectal Cancer: Correlating Phenotype to Genotype
|
5R21CA141187-02
|
$219,583
|
$219,583
|
MUINDI, JOSEPHIA
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Vitamin D3 and Intestinal Tumorigenesis
|
5R21CA143570-02
|
$147,288
|
$147,288
|
AUGENLICHT, LEONARD
|
MONTEFIORE MEDICAL CENTER (BRONX, NY)
|
|
Vitamin D Status, Genetic Variation in Vitamin D Signaling and Metabolism, and Ri
|
5R01CA140285-02
|
$303,435
|
$303,435
|
JACOBS, ELIZABETH
|
UNIVERSITY OF ARIZONA
|
|
VITamin D and omegA-3 triaL (VITAL)
|
5U01CA138962-03
|
$2,728,080
|
$545,616
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Vitamin D and Colorectal Cancer
|
5R01CA122299-04
|
$335,470
|
$335,470
|
BENYA, RICHARD
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Viruses and Cancer
|
2T32CA060395-16
|
$301,776
|
$60,355
|
Courtney, Richard
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
Virus-host interactions in hepatocarcinogenesis
|
5P01CA123328-05
|
$1,042,962
|
$1,042,962
|
OU, J.-H. James
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Virus-gene interactions during hepatic carcinogenesis
|
1R21CA158508-01A1
|
$168,019
|
$168,019
|
CHEN, XIN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Virtual Colonoscopy and Colorectal Cancer Screening
|
5R01CA144835-02
|
$537,020
|
$537,020
|
SMITH, MAUREEN
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Virotherapy for pancreatic cancer with wildtype and armed Myxoma viruses
|
1R21CA149869-01A1
|
$191,183
|
$191,183
|
McFadden, Grant
|
UNIVERSITY OF FLORIDA
|
|
Virginia Mason Community Clinical Oncology Program
|
2U10CA035192-27A1
|
$569,700
|
$62,667
|
Nichols, Craig
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Viral Vaccine Vectors to Prevent Hepatocellular Carcinoma
|
5R01CA131133-04
|
$229,117
|
$229,117
|
ROBEK, MICHAEL
|
YALE UNIVERSITY
|
|
Viral and Cellular Determinants of Hepatitis B Virus Pathogenesis
|
5R01CA056533-19
|
$411,038
|
$411,038
|
Schneider, Robert
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Out
|
ZIA CP010126-00580
|
$48,591
|
$9,718
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
VEGF and PDGF in angiogenesis and tumor progression
|
5R37CA050286-23
|
$460,615
|
$152,003
|
CHERESH, DAVID
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
VCU Minority-Based Community Clinical Oncology Program
|
3U10CA052784-21S1
|
$50,000
|
$8,000
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based Community Clinical Oncology Program
|
5U10CA052784-21
|
$490,679
|
$78,509
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Vascular Modulation for Enhancement of Image-Guided RF Ablation
|
5R21CA131014-02
|
$165,616
|
$165,616
|
Exner, Agata
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Vascular Biology in Cancer
|
ZIA BC 011390
|
$854,488
|
$213,621
|
Lin, Pengnian Charles
|
CCR (NCI)
|
|
Variations in Colonoscopy Screening: A Population Based Study
|
5R01CA131141-04
|
$606,116
|
$606,116
|
BUTTERLY, LYNN
|
DARTMOUTH COLLEGE
|
|
Vanderbilt Proteome Characterization Center
|
1U24CA159988-01
|
$2,862,195
|
$2,862,195
|
LIEBLER, DANIEL
|
VANDERBILT UNIVERSITY
|
|
Vanderbilt In Vivo Cellular and Molecular Imaging Center
|
5P50CA128323-04
|
$1,200,072
|
$336,020
|
GORE, JOHN
|
VANDERBILT UNIVERSITY
|
|
Vanberbilt Biomarker Developmental Laboratory
|
5U01CA152647-02
|
$636,973
|
$318,487
|
Liebler, Daniel
|
VANDERBILT UNIVERSITY
|
|
Validation of Therapeutic Target Genes in Human Liver Cancer
|
ZIA BC 011175
|
$359,902
|
$359,902
|
Thorgeirsson, Snorri
|
CCR (NCI)
|
|
Validation and Fine-Scale Mapping of Pancreatic Cancer Susceptibility Loci
|
1R01CA154823-01A1
|
$761,032
|
$761,032
|
KLEIN, ALISON
|
JOHNS HOPKINS UNIVERSITY
|
|
Validation and extension of the PREMM Model for mismatch repair gene mutations
|
5R01CA132829-04
|
$379,100
|
$379,100
|
SYNGAL, SAPNA
|
DANA-FARBER CANCER INSTITUTE
|
|
Validation and commercialization of a/LCI for detection of esophageal neoplasia
|
2R44CA128163-05
|
$1,000,000
|
$1,000,000
|
Gebhart, Steven
|
ONCOSCOPE, INC.
|
|
Vaccines to promote Tc-1-based targeting of tumor stroma
|
5R01CA140375-02
|
$296,440
|
$148,220
|
Storkus, Walter
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Vaccine-Preventable Cancer Behavior Measurement among Southeast Asian Americans
|
5R21CA152078-02
|
$191,624
|
$95,812
|
Lee, Haeok
|
UNIVERSITY OF MASSACHUSETTS BOSTON
|
|
Vaccine and radiation for the therapy of human cancers
|
ZIA BC 010975
|
$230,674
|
$23,067
|
Hodge, James
|
CCR (NCI)
|
|
Vaccine and Drug Combination Therapy for Human Cancers
|
ZIA BC 010661
|
$269,119
|
$53,823
|
Hodge, James
|
CCR (NCI)
|
|
Utilizing Glycosyltransferases for Bioconjugation
|
ZIA BC 010742
|
$175,228
|
$43,807
|
Qasba, Pradman
|
CCR (NCI)
|
|
Using Targeted Immunotherapy to Enhance Chemotherapy of Colorectal Cancer
|
5R01CA123277-05
|
$302,252
|
$302,252
|
BEDI, ATUL
|
JOHNS HOPKINS UNIVERSITY
|
|
USING PHOTOVOICE TO ENGAGE COMMUNITY MEMBERS IN PROMOTING COLORECTAL CANCER AWARE
|
1R21CA147794-01A1
|
$198,360
|
$198,360
|
James, Aimee
|
WASHINGTON UNIVERSITY
|
|
Using mouse models to probe the relationship of oncogenesis to development and o
|
5U01CA105492-08
|
$743,710
|
$252,861
|
HOLLAND, ERIC
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Using mouse knockouts to unravel endothelial gene function
|
ZIA BC 010736
|
$223,427
|
$22,342
|
St. Croix, Brad
|
CCR (NCI)
|
|
Using Mouse Endoscopy for Evaluating Colon Cancer
|
5R01CA125691-04
|
$351,459
|
$351,459
|
Rosenberg, Daniel
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
Using Ketogenic Diets to Enhance Radio-Chemo-Therapy Response: A Phase I Trial
|
1R21CA161182-01
|
$186,433
|
$93,217
|
Spitz, Douglas
|
UNIVERSITY OF IOWA
|
|
Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based Therapies
|
ZIA BC 005673
|
$680,406
|
$68,040
|
Keefer, Larry
|
CCR (NCI)
|
|
Use of Geographic Variations to Estimate Effectiveness with Non-Randomized Data
|
5R01CA142744-02
|
$469,127
|
$234,564
|
Landrum, Mary
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
|
Use of 2-deoxy-D-glucose & PI3K/Akt pathway inhibitors in head & neck cancer ther
|
5K01CA134941-03
|
$113,750
|
$113,750
|
Burnett, Andrean
|
UNIVERSITY OF IOWA
|
|
Use and Comparative Effectiveness of Innovative Therapies for Hepatocellular Carc
|
1K07CA160722-01
|
$170,100
|
$170,100
|
Sanoff, Hanna
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
Total relevant funding to Digestive Diseases for this search: $464,562,457
|